To the Editor: Dr Davidson and colleagues1 found that sertraline, hypericum (St John's wort),
and placebo had similar efficacy for treatment of depression. I agree with
Kupfer and Frank,2 who stated in their Editorial
that the trial had low assay sensitivity. This does not simply mean low power
for the primary outcome, however. It also indicates that the process and outcome
of the study itself could not answer the postulated question, which is likely
due to multiple small factors that enhance what Moerman and I have called
the meaning or healing response.3 For example,
because sertraline produced more physiological effects than placebo or hypericum,
subjects were not completely blinded to treatment assignment. When physiological
effects of treatment are experienced by some patients receiving an active
treatment in depression studies, effect sizes are falsely elevated unless
an active placebo that mimics these effects is used.4
Such an active placebo was not used in this study.